Management of malignant pleural effusion: challenges and solutions

References

• TaghizadehNFortinMTremblayAUSA hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient SampleChest Epub20161119
   Web of Science ®Google Scholar
• American Thoracic SocietyManagement of malignant pleural effusionsAm J Respir Crit Care Med20001621987200111069845
   PubMed Web of Science ®Google Scholar
• BennettRMaskellNManagement of malignant pleural effusionsCurr Opin Pulm Med20051129630015928495
   PubMed Web of Science ®Google Scholar
• DaviesHEMishraEKKahanBCEffect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trialJAMA20123072383238922610520
   PubMed Web of Science ®Google Scholar
• DemmyTLGuLBurkhalterJEOptimal management of malignant pleural effusions (results of CALGB 30102)J Natl Compr Canc Netw201210897598222878823
   PubMed Web of Science ®Google Scholar
• AntunesGNevilleEDuffyJAliNBTS guidelines for the management of malignant pleural effusionsThorax200358Suppl 2ii29ii3812728148
   PubMed Web of Science ®Google Scholar
• SimoffMJLallyBSladeMGSymptom management in patients with lung cancer – diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest2013143e455Se497S23649452
   PubMed Web of Science ®Google Scholar
• SahnSAPleural diseases related to metastatic malignanciesEur Respir J199710190719019272937
   PubMed Web of Science ®Google Scholar
• SahnSAMalignancy metastatic to the pleuraClin Chest Med1998193513619646986
   PubMed Web of Science ®Google Scholar
• ApffelstaedtJPVan ZylJAMullerAGBreast cancer complicated by pleural effusionJ Surg Oncol1995581731757898113
   PubMed Web of Science ®Google Scholar
• KreismanHWolkoveNFinkelsteinHSCohenCMargoleseRFrankHBreast cancer and thoracic metastasis: review of 119 patientsThorax1983381751796857580
   PubMed Web of Science ®Google Scholar
• WeichselbaumRMarckAHellmanSPathogenesis of pleural effusion in carcinoma of the breastInt J Radiat Oncol Biol Phys19772963965591413
   PubMed Web of Science ®Google Scholar
• ChernowBSahnSACarcinomatous involvement of the pleura: an analysis of 96 patientsAm J Med197763695702930945
   PubMed Web of Science ®Google Scholar
• HsuCCytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patientsDiagn Cytopathol198738123568976
   PubMed Web of Science ®Google Scholar
• JohnstonWWThe malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patientsCancer1985569059094016683
   PubMed Web of Science ®Google Scholar
• SalyerWREgglestonJCErozanYSEfficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleuraChest19756753691126189
   PubMed Web of Science ®Google Scholar
• SearsDHajduSIThe cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusionsActa Cytol19873185973469856
   PubMed Web of Science ®Google Scholar
• HeffnerJENietertPJBarbieriCPleural fluid pH as a predictor of survival for patients with malignant pleural effusionsChest2000117798610631203
   PubMed Web of Science ®Google Scholar
• CliveAOKahanBCHooperCEPredicting survival in malignant pleural effusion: development and validation of the LENT prognostic scoreThorax2014691098110425100651
   PubMed Web of Science ®Google Scholar
• LivingstonRBMcCrackenJDTrauthCJChenTIsolated pleural effusion in small cell lung carcinoma: favorable prognosisChest1982812082106276105
   PubMed Web of Science ®Google Scholar
• DasDKSerous effusions in malignant lymphomas: a reviewDiagn Cytopathol20063433534716604559
   PubMed Web of Science ®Google Scholar
• SahnSAState of the art: the pleuraAm Rev Respir Dis19881381842343059866
   PubMed Web of Science ®Google Scholar
• MeyerPCMetastatic carcinoma of the pleuraThorax1966214374435969243
   PubMed Web of Science ®Google Scholar
• Rodriguez-PanaderoFBorderas NaranjoFLopez-MejiasJPleural metastatic tumours and effusions: frequency and pathogenic mechanisms in a post-mortem seriesEur Respir J198923663692786818
   PubMed Web of Science ®Google Scholar
• ShannonVREapenGAJimenezCARespiratory complicationsKufeDWBast RCJrHaitWCancer Medicine7th edPhiladelphiaBC Decker200621502173
   Google Scholar
• StathopoulosGTKalomenidisIMalignant pleural effusion: tumor-host interactions unleashedAm J Respir Crit Care Med201218648749222652027
   PubMed Web of Science ®Google Scholar
• StathopoulosGTPsallidasIMoustakiAA central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusionJ Natl Cancer Inst20081001464147618840818
   PubMed Web of Science ®Google Scholar
• PsallidasIStathopoulosGTManiatisNASecreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusionOncogene20133252853522370646
   PubMed Web of Science ®Google Scholar
• Martinez-MoragonEAparicioJSanchisJMenendezRRogadoMCSanchisFMalignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 casesRespiration1998651081139580921
   PubMed Web of Science ®Google Scholar
• TammilehtoLMaasilitaPKostianenSAppelqvistPHolstiLRMattsonKDiagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty-five patientsRespiration199252129135
   Google Scholar
• TammilehtoLMalignant mesothelioma: prognostic factors in a prospective study of 98 patientsLung Cancer19928175184
   Google Scholar
• FyshETThomasRSmithNAAustralasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesisPoster presented at: ATS International ConferenceMay 13–18, 2016San Francisco, CA
   Google Scholar
• PutnamJBJrLightRWRodriguezRMA randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusionsCancer1999861992199910570423
   PubMed Web of Science ®Google Scholar
• CliveAOJonesHEBhatnagarRInterventions for the management of malignant pleural effusions: a network meta-analysisCochrane Database Syst Rev2016CD01052927155783
   PubMed Web of Science ®Google Scholar
• DreslerCMOlakJHerndonJE2ndPhase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusionChest200512790991515764775
   PubMed Web of Science ®Google Scholar
• JanssenJPCollierGAstoulPSafety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort studyLancet20073691535153917482984
   PubMed Web of Science ®Google Scholar
• RintoulRCRitchieAJEdwardsJGEfficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trialLancet20143841118112724942631
   PubMed Web of Science ®Google Scholar
• ColtHGThoracoscopy: a prospective study of safety and outcomeChest19951083243297634861
   PubMed Web of Science ®Google Scholar
• TrotterDAlyASiuLKnightSVideo-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital’s experienceHeart Lung Circ200514939716352262
   PubMedGoogle Scholar
• MitrofanCAldeaAGrigorescuCPleurodeza Toracoscopica in pleureziile maligne. [Thoracoscopic pleurodesis in malignant pleural effusions]Rev Med Chir Soc Med Nat Iasi2005109799803 Romanian16612848
   PubMedGoogle Scholar
• LuhSPChenCYTzaoCYMalignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomyThorac Cardiovasc Surg20065433233616902882
   PubMed Web of Science ®Google Scholar
• CardilloGFaccioloFCarboneLLong-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusionsEur J Cardiothorac Surg20022130230611825740
   PubMed Web of Science ®Google Scholar
• ArapisKCaliandroRSternJBGirardPDebrosseDGossotDThoracoscopic palliative treatment of malignant pleural effusions: results in 273 patientsSurg Endosc20062091992316738983
   PubMed Web of Science ®Google Scholar
• RobertsMENevilleEBerrisfordRGAntunesGAliNJManagement of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010Thorax201065Suppl 2ii32ii4020696691
   PubMed Web of Science ®Google Scholar
• WahidiMMReddyCYarmusLRandomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions: the ASAP trialAm J Respir Crit Care Med Epub20161129
   Web of Science ®Google Scholar
• TremblayAMichaudGSingle-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusionChest200612936236816478853
   PubMed Web of Science ®Google Scholar
• SaburNFCheeAStatherDRThe impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusionsRespiration201385364223154202
   PubMed Web of Science ®Google Scholar
• Van MeterMEMcKeeKYKohlwesRJEfficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic reviewJ Gen Intern Med201126707620697963
   PubMed Web of Science ®Google Scholar
• EfthymiouCAMasudiTThorpeJAPapagiannopoulosKMalignant pleural effusion in the presence of trapped lung: five-year experience of PleurX tunnelled cathetersInteract Cardiovasc Thorac Surg2009996196419638358
   PubMedGoogle Scholar
• QureshiRACollinsonSLPowellRJFroeschlePOBerrisfordRGManagement of malignant pleural effusion associated with trapped lung syndromeAsian Cardiovasc Thorac Ann20081612012318381869
   PubMedGoogle Scholar
• PienGWGantMJWashamCLStermanDHUse of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusionChest20011191641164611399685
   PubMed Web of Science ®Google Scholar
• SrourNAmjadiKForsterAAaronSManagement of malignant pleural effusions with indwelling pleural catheters or talc pleurodesisCan Respir J20132010611023616967
   PubMed Web of Science ®Google Scholar
• MekhaielEKashyapRMullonJJMaldonadoFInfections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapyJ Bronchology Interv Pulmonol20132029930324162111
   PubMedGoogle Scholar
• FyshETTremblayAFeller-KopmanDClinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter studyChest20131441597160223828305
   PubMed Web of Science ®Google Scholar
• ThomasRBudgeonCAKuokYJCatheter tract metastasis associated with indwelling pleural cathetersChest201414655756224676503
   PubMed Web of Science ®Google Scholar
• CliveAOTaylorHDobsonLProphylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trialLancet Oncol2016171094110427345639
   PubMed Web of Science ®Google Scholar
• ReddyCErnstALambCFeller-KopmanDRapid pleurodesis for malignant pleural effusions: a pilot studyChest20111391419142320930006
   PubMed Web of Science ®Google Scholar
• BoujaoudeZBartterTAbboudMPratterMAbouzgheibWPleuroscopic pleurodesis combined with tunneled pleural catheter for management of malignant pleural effusion: a prospective observational studyJ Bronchology Interv Pulmonol20152223724326165894
   PubMedGoogle Scholar
• AhmedLIpHRaoDPatelNNoorzadFTalc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathwayChest2014146e190e19425451360
   PubMed Web of Science ®Google Scholar
• BhatnagarRKahanBCMorleyAJThe efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS):study protocol for a randomised controlled trialTrials2015164825880969
   PubMed Web of Science ®Google Scholar
• BjermerLGruberASue-ChuMSandströmTEksborgSHenrikssonREffects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion: a randomised studyEur J Cancer19953122032208
   Web of Science ®Google Scholar
• MasunoTKishimotoSOguraTA comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancerCancer199168149515001893348
   PubMed Web of Science ®Google Scholar
• ZhaoWZWangJKLiWZhangXLClinical research on recombinant human Ad-p53 injection combined with cisplatin in treatment of malignant pleural effusion induced by lung cancerAi Zheng2009288487 Chinese
   Google Scholar
• DuNLiXLiFIntrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusionOncol Rep2013292332234023525453
   PubMed Web of Science ®Google Scholar
• GillenJLauCPermanent indwelling catheters in the management of pleural effusionsThorac Surg Clin201323637123206718
   PubMed Web of Science ®Google Scholar
• EfthymiouCAMasudiTThorpeJAPapagiannopoulosKMalignant pleural effusion in the presence of trapped lung: five-year experience of PleurX tunnelled cathetersInteract Cardiovasc Thorac Surg2009996196419638358
   PubMedGoogle Scholar
• SiorisTSihvoESaloJRäsänenJKnuuttilaALong-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesisEur J Surg Oncol20093554655118644696
   PubMed Web of Science ®Google Scholar
• PienGWGantMJWashamCLStermanDHUse of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusionChest20011191641164611399685
   PubMed Web of Science ®Google Scholar
• LightRWJenkinsonSGMinhVObservations on pleural pressures as fluid is withdrawn during thoracentesisAm Rev Respir Dis19801217998047406313
   PubMed Web of Science ®Google Scholar
• SalamonsenMRLoAKNgACNovel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainageChest20141461286129325010364
   PubMed Web of Science ®Google Scholar
• BoshuizenRCVincentADvan den HeuvelMMComparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusionSupport Care Cancer201321113109311623842597
   PubMed Web of Science ®Google Scholar
• GrosuHBMolinaSCasalRA model to predict pleural effusion recurrencePoster presented at: American Thoracic Society International ConferenceMay 13–18, 2016San Francisco, CA
   Google Scholar
• AnevlavisSKouliatsisGSotiriouIPrognostic factors in patients presenting with pleural effusion revealing malignancyRespiration20148731131624457947
   PubMed Web of Science ®Google Scholar
• SantosGTProllaJCCamilloNDZavalhiaLSRanziADBicaCGClinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusionJ Bras Pneumol20123848749322964933
   PubMed Web of Science ®Google Scholar
• SahnSAGoodJTJrPleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implicationsAnn Intern Med19881083453493341671
   PubMed Web of Science ®Google Scholar
• Rodriguez-PanaderoFLopez-MejiasJSurvival time of patients with pleural metastatic carcinoma predicted by glucose and pH studiesChest1989953203242914482
   PubMed Web of Science ®Google Scholar
• ForestiVScolariNVillaAParisioEDe FilippiGGuareschiGMalignant pleural effusions: meaning of pleural-fluid pH determinationOncology19904762642300387
   PubMed Web of Science ®Google Scholar
• ParkDSKimDHwangKEDiagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusionsYonsei Med J20135439640223364973
   PubMed Web of Science ®Google Scholar
• GörgünDSeçikFMidilliKAkkayaVYıldızPDiagnostic and prognostic significance of survivin levels in malignant pleural effusionRespir Med20131071260126523791464
   PubMed Web of Science ®Google Scholar
• AbraoFCde AbreuIRFogarolliMPrognostic factors of 30–day mortality after palliative procedures in patients with malignant pleural effusionAnn Surg Oncol2015224083408825758190
   PubMed Web of Science ®Google Scholar
• AnevlavisSKouliatsisGSotiriouIPrognostic factors in patients presenting with pleural effusion revealing malignancyRespiration20148731131624457947
   PubMed Web of Science ®Google Scholar
• ZamboniMMda SilvaCTJrBarettaRCunhaETCardosoGPImportant prognostic factors for survival in patients with malignant pleural effusionBMC Pulm Med2015152925887349
   PubMed Web of Science ®Google Scholar
• YoonDWChoJHChoiYSPredictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusionThorac Cancer2016739339827385980
   PubMed Web of Science ®Google Scholar
• FyshETWatererGWKendallPAIndwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusionChest201214239440022406960
   PubMed Web of Science ®Google Scholar
• PenzEMishraEDaviesHEMannsBJMillerRFRahmanNMComparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusionChest2014146991100024832000
   PubMed Web of Science ®Google Scholar
• OlfertJAPenzEDMannsBJCost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusionRespirology Epub20161216
   Web of Science ®Google Scholar
• OldenAMHollowayRTreatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysisJ Palliat Med201013596519839739
   PubMed Web of Science ®Google Scholar
• PuriVPyrdeckTLCrabtreeTDTreatment of malignant pleural effusion: a cost-effectiveness analysisAnn Thorac Surg20129437438022579398
   PubMed Web of Science ®Google Scholar
• ShafiqMFrickKDLeeHYarmusLFeller-KopmanDJManagement of malignant pleural effusion: a cost-utility analysisJ Bronchology Interv Pulmonol20152221522526165892
   PubMedGoogle Scholar
• PsallidasIKalomenidisIPorcelJMRobinsonBWStathopoulosGTMalignant pleural effusion: from bench to bedsideEur Respir Rev20162518919827246596
   PubMed Web of Science ®Google Scholar
• RahmanNMDaviesHESalzbergMUse of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation studyLancet Oncol2008994695218775668
   PubMed Web of Science ®Google Scholar
• LansleySMVergilianaJFCleaverALA commercially available preparation of Staphylococcus aureus bio-products potently inhibits tumour growth in a murine model of mesotheliomaRespirology2014191025103325123375
   PubMed Web of Science ®Google Scholar
• HanHSEomDWKimJHEGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastasesClin Lung Cancer20111238038621729655
   PubMed Web of Science ®Google Scholar
• MatsumoriYYanoSGotoHZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer modelOncol Res200616152616783964
   PubMed Web of Science ®Google Scholar
• PichelmayerOGruenbergerBZielinskiCRadererMBevacizumab is active in malignant effusionAnn Oncol2006171853
   Web of Science ®Google Scholar
• UsuiKSugawaraSNishitsujiMA phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013Lung Cancer20169913113627565928
   PubMed Web of Science ®Google Scholar
• AstoulPViallatJRLaurentJCBrandelyMBoutinCIntrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusionChest19931032092138417880
   PubMed Web of Science ®Google Scholar